Cargando…
Molecular biomarkers of Alzheimer's disease: progress and prospects
The neurodegenerative disorder Alzheimer's disease is characterised by the formation of β-amyloid plaques and neurofibrillary tangles in the brain parenchyma, which cause synapse and neuronal loss. This leads to clinical symptoms, such as progressive memory deficits. Clinically, these pathologi...
Autores principales: | Lashley, Tammaryn, Schott, Jonathan M., Weston, Philip, Murray, Christina E., Wellington, Henny, Keshavan, Ashvini, Foti, Sandrine C., Foiani, Martha, Toombs, Jamie, Rohrer, Jonathan D., Heslegrave, Amanda, Zetterberg, Henrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992610/ https://www.ncbi.nlm.nih.gov/pubmed/29739861 http://dx.doi.org/10.1242/dmm.031781 |
Ejemplares similares
-
Stability of blood-based biomarkers of Alzheimer's disease over multiple freeze-thaw cycles
por: Keshavan, Ashvini, et al.
Publicado: (2018) -
CSF synaptic protein concentrations are raised in those with atypical Alzheimer’s disease but not frontotemporal dementia
por: Clarke, Mica T. M., et al.
Publicado: (2019) -
Amyloid β peptides are differentially vulnerable to preanalytical surface exposure, an effect incompletely mitigated by the use of ratios
por: Toombs, Jamie, et al.
Publicado: (2018) -
Newly identified aspects of tumor suppression by RB
por: Viatour, Patrick, et al.
Publicado: (2011) -
Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments
por: Draoui, Nihed, et al.
Publicado: (2011)